504A.T JPX
Innovacell Inc.
1W: +4.0%
1M: +3.3%
YTD: +27.3%
¥586.00 ($3.71)
-16.00 (-2.66%)
Weekly Expected Move ±6.5%
¥523
¥563
¥602
¥641
¥681
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥27.2B ($172.3M)
52W Range377-1248
Volume96,000
Avg Volume128,992
Beta-0.10
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOColin Lee Novick
Employees48
SectorHealthcare
IndustryBiotechnology
IPO Date2026-02-24
Websiteinnovacell.com
MEGURO VILLA GARDEN 5F
Tokyo, TY 141-0021
JP
Tokyo, TY 141-0021
JP
About Innovacell Inc.
Innovacell Inc. is a biotech company that develops, manufactures, and sells cell therapy and regenerative medicine products aimed at treating fecal and urinary incontinence. The company's pipeline includes treatments for urgent fecal incontinence, leaky fecal incontinence, and stress urinary incontinence using the patient's own cells.
Latest News
No recent news
Recent Insider Trades
No insider trades found